In Depth 13 Mar 2018 The Most Important Battle in Gene Editing: CRISPR versus TALEN …detectable. As a result, CRISPR is less efficient than TALEN when it comes to scaling up edited genomes so it will not be a satisfactory method when it comes to… March 13, 2018 - 6 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jun 2023 Bacterial resistance genes a ‘threat to human health’ …the metagenome, which is the complete gene set of all different organisms in a given sample or within a given environment. Using the method, it is also possible to study… June 5, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 14 Sep 2023 Righting wrongs: genetic justice for Henrietta Lacks …records were given to the press, and her genome was published online, which was then taken off soon after it had garnered backlash. In 2013, the Lacks family came to… September 14, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2017 British and German Scientists Chuck Proteins in the Trash to Uncover their Function …that the new technique could provide a new approach to disease research and support the development of new therapies. Trim-Away acutely degrades endogenous proteins without modifying the genome or mRNA,… November 20, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Nov 2022 The five hottest biotech startup companies in Brazil …with the mission to improve ethnic diversity in collections of human genome sequences. At present, the majority of precision medicine research is based on genomic data from populations with European… November 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Dec 2017 Labiotech’s Favorite Biotechs: Which companies do we like and why? … Synthego. These guys are working on the edge of CRISPR genome engineering after building a bunch of rockets at SpaceX hand-in-hand with Elon Musk. What could be cooler… December 19, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Sep 2025 Navigating German biotech: 14 key players to know …for targeted gene editing Lead program: Preclinical large-serine recombinase (LSR) candidates Seamless Therapeutics is building a gene-editing platform around programmable recombinases that can make large edits to the human genome… September 23, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 5 Feb 2018 A DNA-Based Diagnostic Company Rakes in £1.8M to Combat Antimicrobial Resistance …when it published that its pocket DNA sequencer designed for diagnostic purposes had sequenced the human genome. Meanwhile, liquid biopsies are already well-established in cancer diagnosis. Image via Kateryna Kon… February 5, 2018 - 1 minutemin - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Interview 25 Sep 2017 Meet the Founder & CEO of Galapagos, Europe’s Biotech Role Model …in the human genome, and that’s the core of our target discovery efforts. Are AI and machine learning of any interest to you? Not really, it’s not in our core… September 25, 2017 - 10 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Sponsored by Indivumed Therapeutics 6 Jun 2023 Optimizing early discovery by unraveling cancer complexity within precision therapeutics …and a potential target. This is where the emerging field of multi-omics currently offers promise, highlighted Woodsmith. Multi-omics combines a variety of datasets using different biological analyses spanning the genome,… June 6, 2023 - 7 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
In Depth 21 Nov 2018 5 Challenges to Unlocking the Real Potential of the Human Microbiome …space, including Pfizer and Second Genome, BMS and Enterome, J&J and Vedanta, and Genentech and Microbiotica. As microbiome therapies progress through the clinic, we can expect more investors and big… November 21, 2018 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2022 The biggest US biotech investments in July 2022 …to control gene expression via the epigenome. Replay, a biotech based in San Diego, California, led the U.S. biotech investment seed round rankings in July 2022. The company launched with… August 1, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email